Tocilizumab in Severe COVID- Dead in the Water?

from Saving Lives Podcast: Critical Care w/eddyjoemd · host Eddy Joe Gutierrez, MD

Roche published a press release on 7/29/2020 reflecting the results of the COVACTA study where Actemra/tocilizumab did not improve clinical outcomes nor mortality in patients who had Severe COVID-19 Infections.  Show notes: https://eddyjoemd.com/tocilizumab-covacta/ Receive a FREE audiobook (TWO for Amazon Prime members) with your FREE 30-day trial by using my link for Audible: CLICK HERE! You will be reminded when your trial is ending, by the way. 😉 My website: www.eddyjoemd.com Instagram: www.instagram.com/eddyjoemd Twitter: www.twitter.com/eddyjoemd Facebook: www.facebook.com/eddyjoemd My Amazon store for resources you may find helpful: www.amazon.com/shop/eddyjoemd Although great care has been taken to ensure that the information in this podcast are accurate, eddyjoe, LLC shall not be held responsible or in any way liable for the continued accuracy of the information, or for any errors, omissions or inaccuracies, or for any consequences arising therefrom.